Shares of Sintx Technologies, Inc. (NASDAQ: SINT) rose sharply in today’s pre-market trading after the company announced its subsidiary Technology Assessment & Transfer entered into a Cooperative Research and Development agreement with the U.S.
Haoxi Health Technology experiences a decline in its shares after closing its initial public offering at $4.00 per share, raising $9.60 million for general purposes.